Investment

Features

Fees Safety

Academy

Pluang+

Home/News Feed/SkinMedica launches advisory board and expands R&D to boost regenerative skincare innovation

ABBV

$244.18

-$0.04 -0.02%

SkinMedica launches advisory board and expands R&D to boost regenerative skincare innovation

Company Fundamentals

14 Jul 2026

PRNewsWire

View Source

Bullish

SkinMedica, part of Allergan Aesthetics under AbbVie, has launched a Regenerative Science Advisory Board composed of leading skin health experts to guide future innovation. The company also expanded its R&D facility in Irvine, California, integrating AI and advanced technologies to accelerate skincare research and product development. Additionally, SkinMedica introduced flagship retail experiences in select medical aesthetics practices to enhance patient education and personalized care. These initiatives reinforce SkinMedica's commitment to advancing regenerative skincare through science and collaboration.

More News (ABBV)

Big Pharma faces $300B patent loss, fueling a surge in biotech deals in 2026.

Big pharmaceutical companies are confronting a $300 billion loss in drug patents by 2030, prompting a surge in acquisitions of mid-size biotech firms with promising drug pipelines. In 2026, biopharma deal values are expected to exceed $250 billion, t...

Market News

Bullish

2 days ago